Kakao has agreed to acquire portfolio companies Tapas, for $510m, and Radish, for $440m, as it looks to strengthen its recently merged entertainment subsidiary.

The SAIC, Wanxiang, Full Truck Alliance and Quanta Computer-backed autonomous trucking technology developer will list on the Nasdaq Capital Market through the deal.

The LTL shipping network operator is reportedly targeting $500m in the listing, which would enable corporates Ping An and Yili to exit.

The GV, Louis Dreyfus Company and Emart-backed food development platform creator is pursuing a reverse takeover at a $1.35bn valuation.

AbbVie subsidiary Allergan Aesthetics has agreed to acquire Soliton, which is commercialising a cellulite treatment based on research at University of Texas.

SoftBank vehicle SB Energy and BASF contributed to a $250m PIPE financing that will support the merger with the Nasdaq-listed Acon S2 Acquisition Corp.

The genetic sequencing technology developer has filed to raise up to $100m, having secured nearly $150m from investors including Legend Capital in the past two years.

Cambridge’s gene therapy developer had set terms for an offering set to raise between $135m and $149m on the Nasdaq Global Select Market.

The stem cell-transplant technology developer, partly based on Stanford research, is going public through a reverse merger that will give it a $490m market capitalisation.

The Meituan Dianping, Tencent and Swiss Re-backed health insurance marketplace operator priced its offering at the top of its range.